BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5107863)

  • 1. [Production of leucocyte-deficient preserved blood for prospective graft recipients].
    Goldmann SF; Glavind-Kristensen S; Heiss F; Kissmeyer-Nielsen F
    Munch Med Wochenschr; 1971 Mar; 113(10):358-60. PubMed ID: 5107863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical importance of leukocyte groups in kidney transplantation].
    Freudenberg J
    Internist (Berl); 1971 Mar; 12(3):97-100. PubMed ID: 4396325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood transfusion as a tissue transplant].
    Kruk IN
    Khirurgiia (Mosk); 1981 Oct; (10):115-7. PubMed ID: 7311340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood transfusion and transplantation].
    Ishikura H; Endo J
    Rinsho Byori; 1991 Jul; Suppl 90():139-50. PubMed ID: 1920850
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood component therapy in bone marrow transplantation.
    Brand A; Claas FH; Falkenburg JH; van Rood JJ; Eernisse JG
    Semin Hematol; 1984 Apr; 21(2):141-55. PubMed ID: 6330905
    [No Abstract]   [Full Text] [Related]  

  • 6. Single donor granulocytes and platelets.
    Angela E; Robinson E
    Clin Haematol; 1984 Feb; 13(1):185-216. PubMed ID: 6327131
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of transfusions caused by leukocytes.
    Raife TJ
    J Intraven Nurs; 1997; 20(5):238-44. PubMed ID: 9369624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current risks in blood transfusion in Japan.
    Otsubo H; Yamaguchi K
    Jpn J Infect Dis; 2008 Nov; 61(6):427-33. PubMed ID: 19050347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complications in the transfusion of blood and its derivatives].
    Kazakova LM; Malakhovskiĭ IuE
    Pediatriia; 1980; (9):62-4. PubMed ID: 7001339
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect on cytotoxicity antibodies in potential transplant recipients of leucocyte-poor blood-transfusion.
    Miller WV; Schmidt R; Luke RG; Caywood BE
    Lancet; 1975 Apr; 1(7912):893-5. PubMed ID: 47538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of blood transfusion and their prevention.
    Sandler SG; Yu H; Rassai N
    Clin Adv Hematol Oncol; 2003 May; 1(5):307-13. PubMed ID: 16224428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunology of posttransfusion complications].
    Shabalin VN; Serova LD
    Vestn Khir Im I I Grek; 1982 Oct; 129(10):89-94. PubMed ID: 7179672
    [No Abstract]   [Full Text] [Related]  

  • 16. [Indication for transfusion of preserved autologous blood in elective open heart surgery].
    Ida T; Sakakibara T
    Rinsho Byori; 1991 Mar; Suppl 88():236-42. PubMed ID: 1856974
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion-associated graft-versus-host disease in a newborn.
    Ozdoğan T; Metin F; Doğu A; Timur C; Yildiz E
    J Matern Fetal Neonatal Med; 2007 Mar; 20(3):271-2. PubMed ID: 17450462
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukapheresis and granulocyte transfusion.
    Huestis DW
    Haematologia (Budap); 1982; 15(1):39-55. PubMed ID: 7117942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected CD34 blood cell allografts for older patients: low transplant-related mortality, graft failure and acute GvHD.
    Roberts MM; Dyson P; Rawling C; Thorp D; Rawling T; White D; Horvath N; Bardy P; Hui CH; Dart GW; To LB; Hughes TP
    Cytotherapy; 2003; 5(6):534-41. PubMed ID: 14660049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?].
    Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S
    Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.